Arcturus TherapeuticsARCT

那斯達克 · USD
7.27
+0.17
(+2.39%)
盤中 01/21 11:52 (UTC+8)
01/21 11:52 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.11
  • 0.45
  • 0.31
  • 0.38
  • 0.50
  • 0.42
  • 0.23
  • 0.29
  • 0.28
  • 0.17
icon
  • -86.90
  • 329.13
  • -31.65
  • 23.20
  • 31.17
  • -16.42
  • -45.37
  • 29.06
  • -3.68
  • -39.39
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
17,152
28,301
29,382
22,766
41,673
49,859
38,012
30,855
45,140
10,519
營業成本
----------
營業毛利
17,152
28,301
29,382
22,766
41,673
49,859
38,012
30,855
45,140
10,519
營業費用
33,66339,917-56,160-70,985--64,45465,893
研發費用
23,26529,57834,89343,78039,13458,66953,57336,62051,07752,668
推銷及管理費用
10,39810,33911,31512,38013,27612,31614,85112,50713,37713,225
非經常性項目費用
----------
其他營業費用
----------
營業利益
-16,511
-11,616
-16,826
-33,394
-10,737
-21,126
-30,412
-18,272
-19,314
-55,374
其他收入及費用
3,0632,4402,750-11,8103,6163,7603,963-9,764-5,725-2,328
利息費用
----------
稅前純益
-13,448
-9,176
-14,076
-30,009
-7,121
-17,366
-26,449
-11,445
-15,329
-51,973
所得稅
-4--4-218-150368262893577
稅後純益
-13,448
-9,180
-14,076
-30,005
-6,903
-17,216
-26,817
-11,707
-16,222
-52,550
基本每股稅後盈餘(元)
-0.49-0.34-0.52-1.11-0.26-0.64-1.00-0.32-0.61-1.98
稀釋每股稅後盈餘(元)
-0.49-0.34-0.52-1.11-0.25-0.64-1.00-0.44-0.61-1.94
基本平均股數(千股)
27188.0027129.0027107.0027000.0027062.0026967.0026879.0026628.0026574.0026563.00
稀釋平均股數(千股)
27188.0027129.0027107.0027000.0027062.0026967.0026879.0026628.0026574.0026563.00
還原基本每股稅後盈餘(元)
-0.49-0.34-0.52-1.11-0.26-0.64-1.00-0.32-0.61-1.98
還原稀釋每股稅後盈餘(元)
-0.49-0.34-0.52-1.11-0.25-0.64-1.00-0.44-0.61-1.94
還原基本平均股數(千股)
27,18827,12927,10727,00027,06226,96726,87926,62826,57426,563
還原稀釋平均股數(千股)
27,18827,12927,10727,00027,06226,96726,87926,62826,57426,563
EBITDA(千元)
-12,685-8,397-13,275-29,190-6,209-16,457-25,545-10,630-14,502-51,236

大家都在看

HOT